Research Paper Volume 13, Issue 14 pp 18701—18717
Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
Figure 12. Kaplan–Meier survival analysis is performed on the hub genes. (A) ARRB1, (B) PARP1, (C) PKM, (D) TFDP1, (E) YWHAZ.